CNMD vs MRNA · P/E 19, rev $1.37B vs rev $145.0M
CONMED Corporation (CNMD) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
CONMED Corporation (CNMD) is a medical devices company listed on NYSE.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported CNMD revenue for 2025-12-31 was $1.37B. Net income was $47.1M. Revenue was up 5.2% from 2024-12-31 to 2025-12-31. CNMD currently screens at market cap $1.04B and trailing P/E 19.3.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
CNMD currently screens at market cap $1.04B and trailing P/E 19.3. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the CNMD and MRNA stock pages for the full models.
Not investment advice.